Cite

HARVARD Citation

    Blomme, A. et al. (2022). THEM6‐mediated reprogramming of lipid metabolism supports treatment resistance in prostate cancer. EMBO molecular medicine. 14 (3), p. n/a. [Online]. 
  
Back to record